Our monthly Discussion Groups are hosted by a panel of leading industry experts who explore some of the key issues facing the immuno industry today.
Attendance to our Discussion Groups is available to members of our Immuno Member Community. For more information about Membership, please click here.
Taking place on 23 September 2022 | 10:00 (UTC+1)
Taking place on Monday 24 October 2022 | 15:00 (UTC)
Taking place Monday 28 November | 16:00 (UTC)
Reports and write-ups pertaining to previous Discussion Groups are available in our In-Depth section.
Michael Zaiac, Head of Medical Affairs Oncology Region Europe, Novartis
Paul Rennert, Acting CEO, CSO, Aletabio
Ten-minute Introduction from our discussion group leaders:
Discussion Group Leaders:
Join us for a one hour discussion on understanding the tumour microenvironment with advanced technologies. Our live event aims to bring together key opinion leaders discussing cutting-edge research into the area: from markers through to state of the art technologies to understanding immune response through to cell types of interests in tumour indications, do not miss out on attending the session to stay at the forefront of research.
Panel Discussion: Peripheral Markers To Help Understand The Tumour Microenvironment
Moderator: Paul Jones, Biomarkers Lead, UCB
John Rossi, Senior Vice President and Head of Translational Medicine, Cero Therapeutics
Siddha Kasar, Clinical Translational Lead of Cell Therapies, Takeda